Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Ann Surg. 2015 Jan;261(1):12–17. doi: 10.1097/SLA.0000000000000867

Table 4. Pathological Features of Study Population.

No Neoadjuvant (N = 87) FOLFIRINOX (N = 40) P
Stage <0.001
 I 4 (5%) 10 (25%) 0.006
 IIa 15 (17%) 16 (40%)
 IIb 68 (78%) 14 (35%)
Median size of tumor on pathology (cm) 3.2 (1.5–10.7) 2.5 (0.1–5.5)
N+ 69 (79%) 14 (35%) <0.001
R0 75 (86%) 35 (92%) 0.550
Lymphatic invasion 61 (70%) 14 (35%) <0.001
Perineural invasion 83 (95.4%) 29 (72.5%) <0.001